img

Global Prostaglandin E2 Receptor EP4 Subtype Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prostaglandin E2 Receptor EP4 Subtype Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global Prostaglandin E2 Receptor EP4 Subtype market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, E-7046 accounting for % of the Prostaglandin E2 Receptor EP4 Subtype global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Breast Cancer segment is altered to an % CAGR throughout this forecast period.
The global key companies of Prostaglandin E2 Receptor EP4 Subtype include Eisai Co Ltd, Eli Lilly and Co, Kaken Pharmaceutical Co Ltd, Ono Pharmaceutical Co Ltd, RaQualia Pharma Inc and Rottapharm Biotech Srl, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
The United States Prostaglandin E2 Receptor EP4 Subtype market size was US$ million in 2024, while China size was US$ million. The proportion of the United States was % in 2024, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Prostaglandin E2 Receptor EP4 Subtype landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Prostaglandin E2 Receptor EP4 Subtype market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Prostaglandin E2 Receptor EP4 Subtype market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Prostaglandin E2 Receptor EP4 Subtype market. Readers of the report can become informed about current and future trends of the global Prostaglandin E2 Receptor EP4 Subtype market and how they will impact market growth during the forecast period.



By Company


Eisai Co Ltd
Eli Lilly and Co
Kaken Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
RaQualia Pharma Inc
Rottapharm Biotech Srl
Segment by Type
E-7046
ER-886046
Grapiprant
KAG-308
ONO-4232
Others

Segment by Application


Breast Cancer
Allergies
Chronic Pain
Acute Pain
Lung Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Prostaglandin E2 Receptor EP4 Subtype in global and regional level.
Chapter 3Detailed analysis of Prostaglandin E2 Receptor EP4 Subtype companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostaglandin E2 Receptor EP4 Subtype revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 E-7046
1.2.3 ER-886046
1.2.4 Grapiprant
1.2.5 KAG-308
1.2.6 ONO-4232
1.2.7 Others
1.3 Market by Application
1.3.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Growth Rate by Application: 2018 VS 2024 VS 2034
1.3.2 Breast Cancer
1.3.3 Allergies
1.3.4 Chronic Pain
1.3.5 Acute Pain
1.3.6 Lung Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size (2018-2034)
2.2 Prostaglandin E2 Receptor EP4 Subtype Market Size across Key Geographies Worldwide: 2018 VS 2024 VS 2034
2.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2018-2023)
2.4 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Prostaglandin E2 Receptor EP4 Subtype Countries Ranking by Market Size
3 Prostaglandin E2 Receptor EP4 Subtype Competitive by Company
3.1 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Players
3.1.1 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Players (2018-2023)
3.1.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Players (2018-2023)
3.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Prostaglandin E2 Receptor EP4 Subtype Revenue
3.4 Global Prostaglandin E2 Receptor EP4 Subtype Market Concentration Ratio
3.4.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostaglandin E2 Receptor EP4 Subtype Revenue in 2024
3.5 Global Key Players of Prostaglandin E2 Receptor EP4 Subtype Head office and Area Served
3.6 Global Key Players of Prostaglandin E2 Receptor EP4 Subtype, Product and Application
3.7 Global Key Players of Prostaglandin E2 Receptor EP4 Subtype, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Prostaglandin E2 Receptor EP4 Subtype Breakdown Data by Type
4.1 Global Prostaglandin E2 Receptor EP4 Subtype Historic Revenue by Type (2018-2023)
4.2 Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Revenue by Type (2024-2034)
5 Global Prostaglandin E2 Receptor EP4 Subtype Breakdown Data by Application
5.1 Global Prostaglandin E2 Receptor EP4 Subtype Historic Market Size by Application (2018-2023)
5.2 Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (2021-2023)
6.2 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2018-2034)
6.3 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2018-2034)
6.4 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (2021-2023)
7.2 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2018-2034)
7.3 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2018-2034)
7.4 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (2021-2023)
8.2 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2018-2034)
8.3 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2018-2034)
8.4 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (2021-2023)
9.2 Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2018-2034)
9.3 Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2018-2034)
9.4 Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (2021-2023)
10.2 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2018-2034)
10.3 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2018-2034)
10.4 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Eisai Co Ltd
11.1.1 Eisai Co Ltd Company Details
11.1.2 Eisai Co Ltd Business Overview
11.1.3 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Products and Services
11.1.4 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
11.1.5 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
11.1.6 Eisai Co Ltd Recent Development
11.2 Eli Lilly and Co
11.2.1 Eli Lilly and Co Company Details
11.2.2 Eli Lilly and Co Business Overview
11.2.3 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Products and Services
11.2.4 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
11.2.5 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
11.2.6 Eli Lilly and Co Recent Development
11.3 Kaken Pharmaceutical Co Ltd
11.3.1 Kaken Pharmaceutical Co Ltd Company Details
11.3.2 Kaken Pharmaceutical Co Ltd Business Overview
11.3.3 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Products and Services
11.3.4 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
11.3.5 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
11.3.6 Kaken Pharmaceutical Co Ltd Recent Development
11.4 Ono Pharmaceutical Co Ltd
11.4.1 Ono Pharmaceutical Co Ltd Company Details
11.4.2 Ono Pharmaceutical Co Ltd Business Overview
11.4.3 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Products and Services
11.4.4 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
11.4.5 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
11.4.6 Ono Pharmaceutical Co Ltd Recent Development
11.5 RaQualia Pharma Inc
11.5.1 RaQualia Pharma Inc Company Details
11.5.2 RaQualia Pharma Inc Business Overview
11.5.3 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Products and Services
11.5.4 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
11.5.5 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
11.5.6 RaQualia Pharma Inc Recent Development
11.6 Rottapharm Biotech Srl
11.6.1 Rottapharm Biotech Srl Company Details
11.6.2 Rottapharm Biotech Srl Business Overview
11.6.3 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Products and Services
11.6.4 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
11.6.5 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
11.6.6 Rottapharm Biotech Srl Recent Development
12 Prostaglandin E2 Receptor EP4 Subtype Market Dynamics
12.1 Prostaglandin E2 Receptor EP4 Subtype Industry Trends
12.2 Prostaglandin E2 Receptor EP4 Subtype Market Drivers
12.3 Prostaglandin E2 Receptor EP4 Subtype Market Challenges
12.4 Prostaglandin E2 Receptor EP4 Subtype Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of E-7046
Table 3. Key Players of ER-886046
Table 4. Key Players of Grapiprant
Table 5. Key Players of KAG-308
Table 6. Key Players of ONO-4232
Table 7. Key Players of Others
Table 8. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 9. Global Prostaglandin E2 Receptor EP4 Subtype Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
Table 10. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 12. Global Prostaglandin E2 Receptor EP4 Subtype Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Table 13. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Players (2018-2023) & (US$ Million)
Table 14. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Players (2018-2023)
Table 15. Global Top Prostaglandin E2 Receptor EP4 Subtype Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostaglandin E2 Receptor EP4 Subtype as of 2024)
Table 16. Ranking of Global Top Prostaglandin E2 Receptor EP4 Subtype Companies by Revenue (US$ Million) in 2024
Table 17. Global 5 Largest Players Market Share by Prostaglandin E2 Receptor EP4 Subtype Revenue (CR5 and HHI) & (2018-2023)
Table 18. Global Key Players of Prostaglandin E2 Receptor EP4 Subtype, Headquarters and Area Served
Table 19. Global Key Players of Prostaglandin E2 Receptor EP4 Subtype, Product and Application
Table 20. Global Key Players of Prostaglandin E2 Receptor EP4 Subtype, Date of Enter into This Industry
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2018-2023) & (US$ Million)
Table 23. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2018-2023)
Table 24. Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 25. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2024-2034)
Table 26. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2018-2023) & (US$ Million)
Table 27. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2018-2023)
Table 28. Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 29. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2024-2034)
Table 30. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (2021-2023) & (US$ Million)
Table 31. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2018-2023) & (US$ Million)
Table 32. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2024-2034) & (US$ Million)
Table 33. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2018-2023) & (US$ Million)
Table 34. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2024-2034) & (US$ Million)
Table 35. North America Prostaglandin E2 Receptor EP4 Subtype Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2018-2023) & (US$ Million)
Table 37. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2024-2034) & (US$ Million)
Table 38. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (2021-2023) & (US$ Million)
Table 39. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2018-2023) & (US$ Million)
Table 40. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2024-2034) & (US$ Million)
Table 41. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2018-2023) & (US$ Million)
Table 42. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2024-2034) & (US$ Million)
Table 43. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2018-2023) & (US$ Million)
Table 45. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2024-2034) & (US$ Million)
Table 46. Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (2021-2023) & (US$ Million)
Table 47. Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2018-2023) & (US$ Million)
Table 48. Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2024-2034) & (US$ Million)
Table 49. Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2018-2023) & (US$ Million)
Table 50. Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2024-2034) & (US$ Million)
Table 51. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 52. Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Region (2018-2023) & (US$ Million)
Table 53. Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Region (2024-2034) & (US$ Million)
Table 54. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (2021-2023) & (US$ Million)
Table 55. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2018-2023) & (US$ Million)
Table 56. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2024-2034) & (US$ Million)
Table 57. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2018-2023) & (US$ Million)
Table 58. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2024-2034) & (US$ Million)
Table 59. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 60. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2018-2023) & (US$ Million)
Table 61. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2024-2034) & (US$ Million)
Table 62. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (2021-2023) & (US$ Million)
Table 63. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2018-2023) & (US$ Million)
Table 64. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2024-2034) & (US$ Million)
Table 65. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2024-2034) & (US$ Million)
Table 67. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 68. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2018-2023) & (US$ Million)
Table 69. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2024-2034) & (US$ Million)
Table 70. Eisai Co Ltd Company Details
Table 71. Eisai Co Ltd Business Overview
Table 72. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 73. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023) & (US$ Million)
Table 74. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
Table 75. Eisai Co Ltd Recent Development
Table 76. Eli Lilly and Co Company Details
Table 77. Eli Lilly and Co Business Overview
Table 78. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 79. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023) & (US$ Million)
Table 80. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
Table 81. Eli Lilly and Co Recent Development
Table 82. Kaken Pharmaceutical Co Ltd Company Details
Table 83. Kaken Pharmaceutical Co Ltd Business Overview
Table 84. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 85. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023) & (US$ Million)
Table 86. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
Table 87. Kaken Pharmaceutical Co Ltd Recent Development
Table 88. Ono Pharmaceutical Co Ltd Company Details
Table 89. Ono Pharmaceutical Co Ltd Business Overview
Table 90. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 91. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023) & (US$ Million)
Table 92. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
Table 93. Ono Pharmaceutical Co Ltd Recent Development
Table 94. RaQualia Pharma Inc Company Details
Table 95. RaQualia Pharma Inc Business Overview
Table 96. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 97. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023) & (US$ Million)
Table 98. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
Table 99. RaQualia Pharma Inc Recent Development
Table 100. Rottapharm Biotech Srl Company Details
Table 101. Rottapharm Biotech Srl Business Overview
Table 102. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 103. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023) & (US$ Million)
Table 104. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype SWOT Analysis
Table 105. Rottapharm Biotech Srl Recent Development
Table 106. Prostaglandin E2 Receptor EP4 Subtype Market Trends
Table 107. Prostaglandin E2 Receptor EP4 Subtype Market Drivers
Table 108. Prostaglandin E2 Receptor EP4 Subtype Market Challenges
Table 109. Prostaglandin E2 Receptor EP4 Subtype Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostaglandin E2 Receptor EP4 Subtype Product Picture
Figure 2. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (US$ Million): 2018 VS 2024 VS 2034
Figure 3. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Type: 2024 VS 2034
Figure 4. E-7046 Features
Figure 5. ER-886046 Features
Figure 6. Grapiprant Features
Figure 7. KAG-308 Features
Figure 8. ONO-4232 Features
Figure 9. Others Features
Figure 10. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (US$ Million): 2018 VS 2024 VS 2034
Figure 11. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Application: 2024 VS 2034
Figure 12. Breast Cancer
Figure 13. Allergies
Figure 14. Chronic Pain
Figure 15. Acute Pain
Figure 16. Lung Cancer
Figure 17. Others
Figure 18. Prostaglandin E2 Receptor EP4 Subtype Report Years Considered
Figure 19. Global Prostaglandin E2 Receptor EP4 Subtype Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 20. Global Prostaglandin E2 Receptor EP4 Subtype Market Size 2018-2034 (US$ Million)
Figure 21. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Market Share by Region: 2024 VS 2034
Figure 22. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Region in 2018 VS 2024
Figure 23. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share Forecast by Region (2024-2034)
Figure 24. Global Top 10 Prostaglandin E2 Receptor EP4 Subtype Countries Ranking by Market Size (US$ Million) in 2024
Figure 25. Global Prostaglandin E2 Receptor EP4 Subtype Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Figure 26. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Players in 2024
Figure 27. Global Top Prostaglandin E2 Receptor EP4 Subtype Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostaglandin E2 Receptor EP4 Subtype as of 2024)
Figure 28. The Top 10 and 5 Players Market Share by Prostaglandin E2 Receptor EP4 Subtype Revenue in 2024
Figure 29. North America Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Company in 2024
Figure 30. North America Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2018-2034)
Figure 31. North America Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2018-2034)
Figure 32. North America Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Country (2018-2034)
Figure 33. U.S. Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 34. Canada Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 35. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Company in 2024
Figure 36. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2018-2034)
Figure 37. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2018-2034)
Figure 38. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Country (2018-2034)
Figure 39. Germany Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 40. France Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 41. U.K. Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 42. Italy Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 43. Russia Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 44. Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Company in 2024
Figure 45. Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2018-2034)
Figure 46. Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2018-2034)
Figure 47. Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Region (2018-2034)
Figure 48. China Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 49. Japan Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 50. South Korea Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 51. India Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 52. Australia Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 53. Taiwan Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 54. Indonesia Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 55. Thailand Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 56. Malaysia Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 57. Philippines Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 58. Vietnam Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 59. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Company in 2024
Figure 60. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2018-2034)
Figure 61. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2018-2034)
Figure 62. Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Country (2018-2034)
Figure 63. Mexico Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 64. Brazil Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 65. Argentina Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 66. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Company in 2024
Figure 67. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2018-2034)
Figure 68. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2018-2034)
Figure 69. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Country (2018-2034)
Figure 70. Turkey Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 71. Saudi Arabia Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 72. UAE Prostaglandin E2 Receptor EP4 Subtype Revenue (2018-2034) & (US$ Million)
Figure 73. Eisai Co Ltd Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
Figure 74. Eli Lilly and Co Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
Figure 75. Kaken Pharmaceutical Co Ltd Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
Figure 76. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
Figure 77. RaQualia Pharma Inc Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
Figure 78. Rottapharm Biotech Srl Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2018-2023)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries